Expression of three different mutations in the arginine vasopressin gene suggests genotype-phenotype correlation in familial neurohypophyseal diabetes insipidus kindreds: (Genotype-phenotype correlation in familial neurohypophyseal diabetes insipidus)

Clinical Endocrinology

Volumn 63, Issue 2, 2005, Pages 207-216

  Siggaard, Charlotte ^a   Christensen, Jane H ^a   Corydon, Thomas J ^b   Rittig, Søren ^a   Robertson, Gary L ^c   Gregersen, Niels ^a   Bolund, Lars ^b   Pedersen, Erling B ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c NORTHWESTERN UNIVERSITY   (United States)

^d HOLSTEBRO HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN;

ANIMAL CELL; ARTICLE; CASE REPORT; CELL LINE; CELL MUTANT; CHILD; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES INSIPIDUS; ENDOPLASMIC RETICULUM; FAMILIAL DISEASE; FAMILIAL NEUROHYPOPHYSEAL DIABETES INSIPIDUS; GENE EXPRESSION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MOUSE; NEUROHYPOPHYSIS DISEASE; NONHUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ARGININE VASOPRESSIN; CELL LINE, TUMOR; CHILD; DIABETES INSIPIDUS, NEUROGENIC; FAMILY HEALTH; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; IMMUNOPRECIPITATION; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MUTATION; PHENOTYPE; PROTEINS;

EID: 23244440884     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02327.x     Document Type: Article

References (49)

1. Baylis, P.H. & Robertson, G.L. (1981) Vasopressin function in familial cranial diabetes insipidus. Postgraduate Medical Journal, 57, 36-40.
2. Kaplowitz, P.B., D'Ercole, A.J. & Robertson, G.L. (1982) Radioimmunoassay of vasopressin in familial cental diabetes insipidus. Journal of Pediatrics, 100, 76-81.
3. Blackett, P.R., Seif, S.M., Altmiller, D.H. & Robinson, A.G. (1983) Familial central diabetes insipidus: vasopressin and nicotine stimulated neurophysin deficiency with subnormal oxytocin and estrogen stimulated neurophysin. American Journal of the Medical Sciences, 286, 42-46.
4. Pedersen, E.B., Lamm, L.U., Albertsen, K., Madsen, M., Bruun-Petersen, G., Henningsen, K., Friedrich, U. & Magnusson, K. (1985) Familial cranial diabetes insipidus: a report of five families. Genetic, diagnostic and therapeutic aspects. Quarterly Journal of Medicine, 57, 883-896.
5. Os, I., Aakesson, I. & Enger, E. (1985) Plasma vasopressin in hereditary cranial diabetes insipidus. Acta Medica Scandinavica, 217, 429-434.
6. McLeod, J.F., Kovacs, L., Gaskill, M.B., Rittig, S., Bradley, G.S. & Robertson, G.L. (1993) Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation [see comments]. Journal of Clinical Endocrinology & Metabolism, 77, 599A-599G.
7. Mahoney, C.P., Weinberger, E., Bryant, C., Ito, M., Jameson, J.L. & Ito, M. (2002) Effects of aging on vasopressin production in a kindred with autosomal dominant neurohypophyseal diabetes insipidus due to the DeltaE47 neurophysin mutation. Journal of Clinical Endocrinology & Metabolism, 87, 870-876.
8. Elias, P.C., Elias, L.L., Torres, N., Moreira, A.C., Antunes-Rodrigues, J. & Castro, M. (2003) Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene. Clinical Endocrinology, 59, 511-518.
9. Bergeron, C., Kovacs, K., Ezrin, C. & Mizzen, C. (1991) Hereditary diabetes insipidus: an immunohistochemical study of the hypothalamus and pituitary gland. Acta Neuropathologica, 81, 345-348.
10. Sausville, E., Carney, D. & Battey, J. (1985) The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. Journal of Biological Chemistry, 260, 10236-10241.
11. Barat, C., Simpson, L. & Breslow, E. (2004) Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus. Biochemistry, 43, 8191-8203.
12. Wolf, M.T., Dotsch, J., Metzler, M., Holder, M., Repp, R. & Rascher, W. (2003) A new missense mutation of the vasopressin-neurophysin II gene in a family with neurohypophyseal diabetes insipidus. Hormone Research, 60, 143-147.
13. Miyakoshi, M., Kamoi, K., Murase, T., Sugimura, Y. & Oiso, Y. (2004) Novel mutant vasopressin-neurophysin II gene associated with familial neurohypophyseal diabetes insipidus. Endocrine Journal, 51, 551-556.
14. Baglioni, S., Corona, G., Maggi, M., Serio, M. & Peri, A. (2004) Identification of a novel mutation in the arginine vasopressin-neurophysin II gene affecting the sixth intrachain disulfide bridge of the neurophysin II moiety. European Journal of Endocrinology, 151, 605-611.
15. Wahlstrom, J.T., Fowler, M.J., Nicholson, W.E. & Kovacs, W.J. (2004) A novel mutation in the preprovasopressin gene identified in a kindred with autosomal dominant neurohypophyseal diabetes insipidus. Journal of Clinical Endocrinology & Metabolism, 89, 1963-1968.
16. Christensen, J.H., Siggaard, G, Corydon, T.J., deSanctis, L., Kovacs, L., Robertson, G.L., Gregersen, N. & Rittig, S. (2004a) Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis. European Journal of Human Genetics, 12, 44-51.
17. Rittig, S., Robertson, G.L., Siggaard, C., Kovacs, L., Gregersen, N., Nyborg, J. & Pedersen, E.B. (1996) Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. American Journal of Human Genetics, 58, 107-117.
18. Olias, G., Richter, D. & Schmale, H. (1996) Heterologous expression of human vasopressin-neurophysin precursors in a pituitary cell line: defective transport of a mutant protein from patients with familial diabetes insipidus. DNA and Cell Biology, 15, 929-935.
19. Ito, M. & Jameson, J.L. (1997) Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. Journal of Clinical Investigation, 99, 1897-1905.
20. Beuret, N., Rutishauser, J., Bider, M.D. & Spiess, M. (1999) Mechanism of endoplasmic reticulum retention of mutant vasopressin precursor caused by a signal peptide truncation associated with diabetes insipidus. Journal of Biological Chemistry, 274, 18965-18972.
21. Siggaard, C., Rittig, S., Corydon, T.J., Andreasen, P.H., Jensen, T.G., Andresen, B.S., Robertson, G.L., Gregersen, N., Bolund, L. & Pedersen, E.B. (1999) Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation. Journal of Clinical Endocrinology & Metabolism, 84, 2933-2941.
22. Nijenhuis, M., Zalm, R. & Burbach, J.P. (1999) Mutations in the vasopressin prohormone involved in diabetes insipidus impair endoplasmic reticulum export but not sorting. Journal of Biological Chemistry, 274, 21200-21208.
23. Nijenhuis, M., Zalm, R. & Burbach, J.P. (2000) A diabetes insipidus vasopressin prohormone altered outside the central core of neurophysin accumulates in the endoplasmic reticulum. Molecular and Cellular Endocrinology, 167, 55-67.
24. Nijenhuis, M., van den Akker, E.L., Zalm, R., Franken, A.A., Abbes, A.P., Engel, H., de Wied, D. & Burbach, J.P. (2001) Familial neurohypophysial diabetes insipidus in a large Dutch kindred: effect of the onset of diabetes on growth in children and cell biological defects of the mutant vasopressin prohormone. Journal of Clinical Endocrinology & Metabolism, 86, 3410-3420.
25. Christensen, J.H., Siggaard, C., Corydon, T.J., Robertson, G.L., Gregersen, N., Bolund, L. & Rittig, S. (2004b) Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus. Journal of Clinical Endocrinology & Metabolism, 89, 4521-4531.
26. Christensen, J.H., Siggaard, C., Corydon, T.J., Robertson, G.L., Gregersen, N., Bolund, L. & Rittig, S. (2004c) Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus. Clinical Endocrinology, 60, 125-136.
27. Si-Hoe, S., de Bree, F.M., Nijenhuis, M., Davies, J.E., Howell, L.M., Tinley, H., Waller, S.J., Zeng, Q., Zalm, R., Sonnemans, M., Van Leeuwen, F.W., Burbach, J.P. & Murphy, D. (2000) Endoplasmic reticulum derangement in hypothalamic neurons of rats expressing a familial neurohypophyseal diabetes insipidus mutant vasopressin transgene. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 14, 1680-1684.
28. Davies, J. & Murphy, D. (2002) Autophagy in hypothalamic neurones of rats expressing a familial neurohypophysial diabetes insipidus transgene. Journal of Neuroendocrinology, 14, 629-637.
29. Russell, T.A., Ito, M., Ito, M., Yu R.N., Martinson, F.A., Weiss, J. & Jameson, J.L. (2003) A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. Journal of Clinical Investigation, 112, 1697-1706.
30. Zerbe, R.L. & Robertson, G.L. (1981) A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. New England Journal of Medicine, 305, 1539-1546.
31. Danielsen, H., Pedersen, E.B. & Spencer, E.S. (1984) Effect of indapamide on the renin-aldosterone system, and urinary excretion of potassium and calcium in essential hypertension. British Journal of Clinical Pharmacology, 18, 229-231.
32. Bie, P. & Sandgaard, N.C. (2000) Determinants of the natriuresis after acute, slow sodium loading in conscious dogs. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 278, R1-R10.
33. Corydon, T.J., Wilsbech, M., Jespersgaard, C., Andresen, B.S., Borglum, A.D., Pedersen, S., Bolund, L., Gregersen, N. & Bross, P. (2000) Human and mouse mitochondrial orthologs of bacterial ClpX. Mammalian Genome: Official Journal of the Inter national Mammalian Genome Society, 11, 899-905.
34. Lacombe, U. (1841) De la polydipsie. L'experiance. Journal de Medecine et de Chirurgie, 7, 323-339.
35. de Bree, F.M. & Burbach, J.P. (1994) Heterologous biosynthesis and processing of preprovasopressin in Neuro2A neuroblastoma cells. Biochimie, 76, 315-319.
36. de Bree, F.M., Van Der Kleij, A.A., Nijenhuis, M., Zalm, R., Murphy, D. & Burbach, J.P. (2003) The Hormone Domain of the Vasopressin Prohormone is Required for the Correct Prohormone Trafficking Through the Secretory Pathway. Journal of Neuroendocrinology, 15, 1156-1163.
37. Eubanks, S., Nguyen, T.L., Deeb, R., Villafania, A., Alfadhli, A. & Breslow, E. (2001) Effects of diabetes insipidus mutations on neurophysin folding and function. Journal of Biological Chemistry, 276, 29671-29680.
38. von Heijne, G. (1984) How signal sequences maintain cleavage specificity. Journal of Molecular Biology, 173, 243-251.
39. Folz, R.J., Nothwehr, S.F. & Gordon, J.I. (1988) Substrate specificity of eukaryotic signal peptidase. Site-saturation mutagenesis at position-1 regulates cleavage between multiple sites in human pre (delta pro) apolipoprotein A-II. Journal of Biological Chemistry, 263, 2070-2078.
40. von Heijne, G. (1990) The signal peptide. Journal of Membrane Biology, 115, 195-201.
41. Fikes, J.D., Barkocy-Gallagher, G.A., Klapper, D.G. & Bassford, P.J. Jr (1990) Maturation of Escherichia coli maltose-binding protein by signal peptidase I in vivo. Sequence requirements for efficient processing and demonstration of an alternate cleavage site. Journal of Biological Chemistry, 265, 3417-3423.
42. Laforet, G.A. & Kendall, D.A. (1991) Functional limits of conformation, hydrophobicity, and steric constraints in prokaryotic signal peptide cleavage regions. Wild type transport by a simple polymeric signal sequence. Journal of Biological Chemistry, 266, 1326-1334.
43. Breslow, E. (1993) Structure and folding properties of neurophysin and its peptide complexes: biological implications. Regulatory Peptides, 45, 15-19.
44. Hansen, L.K., Rittig, S. & Robertson, G.L. (1997) Genetic basis of familial neurohypophyseal diabetes insipidus. Trends in Endocrinology and Metabolism, 8, 363-372.
45. Johnston, J.A., Ward, C.L. & Kopito, R.R. (1998) Aggresomes: a cellular response to misfolded proteins. Journal of Cell Biology, 143, 1883-1898.
46. Kopito, R.R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends in Cell Biology, 10, 524-530.
47. Calvo, B., Bilbao, J.R., Urrutia, I., Eizaguirre, J., Gaztambide, S. & Castano, L. (1998) Identification of a novel nonsense mutation and a missense substitution in the vasopressin-neurophysin II gene in two Spanish kindreds with familial neurohypophyseal diabetes insipidus. Journal of Clinical Endocrinology & Metabolism, 83, 995-997.
48. Boson, W.L., Sarubi, J.C., D'Alva, C.B., Friedman, E., Faria, D., De Marco, L. & Wajchenberg, B. (2003) A signal peptide mutation of the arginine vasopressin gene in monozygotic twins. Clinical Endocrinology, 58, 108-110.
49. Repaske, D.R., Medlej, R., Gultekin, E.K., Krishnamani, M.R., Halaby, G., Findling, J.W. & Phillips, J.A. (1997) Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1→Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor. Journal of Clinical Endocrinology & Metabolism, 82, 51-56.